menu search

5 minute learning machine: doubling your power to learn in only 5 minutes… guaranteed

Product Name: 5 Minute Learning Machine: Doubling Your Power To Learn In Only 5 Minutes… Guaranteed Read moreDiscover Brazil "from North to South" �...

May 28, 2023, 10:12 am

Dyne therapeutics: force platform poised to revolutionize gene therapy

Dyne Therapeutics, Inc. has announced that its investigational therapeutic, DYNE-251, for Duchenne musc...

May 27, 2023, 10:02 pm

Target, bud light investors lose billions on marketing misses

Investors in Target and Bud Light parent Anheuser-Busch are getting punished after a string of marketin...

May 26, 2023, 2:15 pm

Post-operative pain management market size to hit usd 4.59 billion by 2030 at 6.8% cagr – report by market research future (mrfr)

Post-Operative Pain Management Market Trends And Insights By Pain Type (Acute Pain, Moderate Pain, Severe Pain), By Products (Non-Steroidal Anti-Infla...

May 25, 2023, 7:20 pm

Anheuser-busch's stock falls again toward 6-month low, heads for worst month in nearly two years

The U.S.-listed shares of Anheuser-Busch InBev S.A. BUD, -1.26% dropped 1.3% in afternoon trading, whic...

May 25, 2023, 2:55 pm

Finance experts set bud light stock price for the end of 2023

Anheuser-Busch InBev (NYSE: BUD), the owner of Bud Light, has experienced a continued decline in sales ...

May 25, 2023, 8:40 am

: sarepta says fda is working toward accelerated approval of its latest treatment for duchenne muscular dystrophy

Sarepta Therapeutics Inc. SRPT said Wednesday that the U.S. Food and Drug Administration has indicated after talks with the company that it’s workin...

May 24, 2023, 4:59 pm

Si-bone to present at jefferies 2023 healthcare conference on june 7, 2023

SANTA CLARA, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving m...

May 24, 2023, 4:09 pm

Why shares of sarepta therapeutics are dropping wednesday

Sarepta focuses on gene therapies to treat rare diseases. SRP-9001 is designed to correct the genetic mutation that can cause Duchenne m...

May 24, 2023, 1:53 pm

Siemens ceo confident chinese market is 'picking up'

Siemens Chief Executive Officer Roland Busch explains why the company remains confident in demand from ...

May 24, 2023, 9:10 am

Fda defers decision for sarepta's gene therapy to june 22

The U.S. Food and Drug Administration has deferred its decision on an accelerated approval for Sarepta Therapeutics Inc's gene therapy for a m...

May 24, 2023, 8:17 am

Sarepta says fda is working toward accelerated approval of its latest treatment for duchenne muscular dystrophy

Sarepta Therapeutics Inc. SRPT, -1.45% said Wednesday that the U.S. Food and Drug Administration has indicated after talks with the company that it's ...

May 24, 2023, 8:15 am

Anheuser-busch inbev: sales plummeting, stock at critical support

The controversy over a recent Anheuser-Busch InBev SA/NV marketing campaign has been well-publicized. T...

May 23, 2023, 4:43 pm

Gold, silver down as greenback bulls flex their muscles

(Kitco News) - Gold and silver prices are lower in midday U.S. trading Tuesday, but up from their daily lows. Silver notched a seven-week low today....

May 23, 2023, 11:59 am

Patrick drahi may be stake building at bt, but he's yet to exert his influence

Patrick Drahi hasn't requested a seat in the boardroom at BT just yet, and it may be a few years until he really starts to flex his m...

May 23, 2023, 10:31 am

Bud light distributor blasts anheuser-busch over dylan mulvaney: ‘we do not support this'

"We too at Bama Budweiser are upset about it and have made our feelings known to the top leadership at Anheuser-B...

May 23, 2023, 10:08 am

Psyched wellness is excited to announce the launch of amanita gummies with my crew doses inc., a natural formulation house and brand

Toronto, Ontario--(Newsfile Corp. - May 23, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life s...

May 23, 2023, 7:30 am

‘there is a subset of american consumers who will not drink a bud light for the foreseeable future.' anheuser-busch inbev's u.s. profits may tumble, jpmorgan says

The controversy over briefly having a transgender influencer promote Bud Light may hit U.S. profits substantially at Anheuser-B...

May 23, 2023, 5:57 am

As bud slips, heineken plots further shake-up of u.s. light beer

As investors try to assess the fallout on global brewing leader Anheuser-Busch InBev from a backlash ag...

May 23, 2023, 2:03 am

Nzd/usd price analysis: kiwi buyers flex muscles despite recent inaction below 0.6300

NZD/USD remains depressed inside immediate triangle formation. Golden cross, steady RSI keeps Kiwi pair buyers hopeful. Bulls need validation from 0.6...

May 23, 2023, 12:29 am


Search within

Pages Search Results: